Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation
- PMID: 6491983
Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation
Abstract
Earlier studies demonstrating marked differences in the profile of polar metabolites formed during incubations of glutathione, naphthalene and microsomes from target (lung) and nontarget (liver and kidney) tissues of the mouse suggested that the formation of a particular reactive metabolite may be the underlying basis for the highly organ selective toxicity of this hydrocarbon. The studies reported here were done to characterize more fully the microsomal metabolism of naphthalene to 1,2-dihydro-1,2-dihydroxynaphthalene and to three glutathione-derived conjugates that were separated by high-pressure liquid chromatography. The microsomal formation of polar naphthalene metabolites was linear with time and microsomal protein; the relative proportions of each of the metabolites remained relatively stable over the range of time and protein concentrations studied. The rate of formation of naphthalene glutathione adducts, but not the dihydrodiol, was dependent upon the amount of 100,000 X g supernatant protein added. Addition of lung cytosol to liver microsomal incubations or liver cytosol to lung microsomal incubations altered the overall rate of conjugate formation but not the relative proportions of each of the three conjugate peaks. Epoxide hydrolase induction by dietary butylated hydroxyanisole or inhibition by cyclohexene oxide altered the rate of hepatic microsomal formation of naphthalene dihydrodiol in the expected manner and increased the production of conjugate peak 2. Butylated hydroxyanisole or cyclohexene oxide failed to alter the rate of formation of conjugate peak 1 or 3. Addition of piperonyl butoxide or SKF 525-A to hepatic microsomal incubations markedly decreased covalent binding of naphthalene metabolites but only slightly decreased glutathione adduct formation. Dihydrodiol formation was increased by both inhibitors. Phenobarbital or 3-methylcholanthrene pretreatment produced a marked increase in the pulmonary microsome-catalyzed formation of all four polar naphthalene metabolites. In comparison, phenobarbital increased the rates of formation of the dihydrodiol, conjugate peaks 1 and 2 but not 3 in hepatic microsomes. 3-Methylcholanthrene increased the rate of formation of the dihydrodiol and conjugate peak 2 but not 1 or 3. These studies indicate that the predominant formation of conjugate peak 2 in lung microsomal incubations in comparison to liver microsomal incubations is due to the regio- or stereoselectivity of naphthalene metabolism by cytochrome P-450 monooxygenases or epoxide hydrolases but not by the glutathione transferases.
Similar articles
-
Evidence for hepatic formation, export and covalent binding of reactive naphthalene metabolites in extrahepatic tissues in vivo.J Pharmacol Exp Ther. 1983 Apr;225(1):8-16. J Pharmacol Exp Ther. 1983. PMID: 6834280
-
Relationship of cytochrome P450 activity to Clara cell cytotoxicity. II. Comparison of stereoselectivity of naphthalene epoxidation in lung and nasal mucosa of mouse, hamster, rat and rhesus monkey.J Pharmacol Exp Ther. 1992 Apr;261(1):364-72. J Pharmacol Exp Ther. 1992. PMID: 1560380
-
The in vitro formation of glutathione conjugates with the microsomally activated pulmonary bronchiolar aklylating agent and cytotoxin, 4-ipomeanol.J Pharmacol Exp Ther. 1980 Oct;215(1):97-103. J Pharmacol Exp Ther. 1980. PMID: 7452496
-
Characterization of rat lung epoxide (styrene oxide) hydrase with a modified radioactive assay of improved sensitivity.Cancer Res. 1977 Apr;37(4):1075-82. Cancer Res. 1977. PMID: 402999 Review.
-
Review of the biochemical effects of Lantana camara toxicity.Vet Hum Toxicol. 1984 Dec;26(6):488-93. Vet Hum Toxicol. 1984. PMID: 6393560 Review.
Cited by
-
Toxicity and metabolism of methylnaphthalenes: comparison with naphthalene and 1-nitronaphthalene.Toxicology. 2009 Jun 16;260(1-3):16-27. doi: 10.1016/j.tox.2009.03.002. Epub 2009 Mar 18. Toxicology. 2009. PMID: 19464565 Free PMC article. Review.
-
A preliminary physiologically based pharmacokinetic model for naphthalene and naphthalene oxide in mice and rats.Ann Biomed Eng. 1996 Mar-Apr;24(2):305-20. doi: 10.1007/BF02667357. Ann Biomed Eng. 1996. PMID: 8678360
-
A comparative study of the kinetics and bioavailability of pure and soil-adsorbed naphthalene in dermally exposed male rats.Arch Environ Contam Toxicol. 1994 May;26(4):504-9. doi: 10.1007/BF00214154. Arch Environ Contam Toxicol. 1994. PMID: 8198429
-
Impact of hepatic P450-mediated biotransformation on the disposition and respiratory tract toxicity of inhaled naphthalene.Toxicol Appl Pharmacol. 2017 Aug 15;329:1-8. doi: 10.1016/j.taap.2017.05.015. Epub 2017 May 18. Toxicol Appl Pharmacol. 2017. PMID: 28527914 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources